Rossari Biotech Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	23,964	20,803	18,306	16,559	14,830
Revenue Growth (YoY)	15.19%	13.64%	10.55%	11.66%	109.06%
Cost of Revenue	16,687	14,393	13,007	11,765	11,121
Gross Profit	7,276	6,410	5,298	4,794	3,708
Selling, General & Admin	1,547	1,401	1,098	1,039	726.02
Other Operating Expenses	2,870	2,466	1,769	1,609	1,200
Operating Expenses	5,209	4,538	3,471	3,277	2,416
Operating Income	2,068	1,872	1,827	1,516	1,292
Interest Expense	-285.43	-178.11	-193.72	-223.15	-126.56
Interest & Investment Income	-	8.57	22.39	25.21	49.77
Earnings From Equity Investments	19.01	9.78	1.75	9.57	15.47
Currency Exchange Gain (Loss)	-	108.23	66.77	84.61	62.05
Other Non Operating Income (Expenses)	223.78	12.94	7.32	5.06	50.8
EBT Excluding Unusual Items	2,025	1,834	1,732	1,418	1,344
Gain (Loss) on Sale of Investments	-	18.98	25.68	7.07	12.52
Gain (Loss) on Sale of Assets	-	-0.69	18.78	2.83	6.38
Other Unusual Items	-	-	-	14.67	-
Pretax Income	2,025	1,852	1,776	1,442	1,363
Income Tax Expense	533.02	488.07	469.26	369.62	385.8
Earnings From Continuing Operations	1,492	1,364	1,307	1,073	976.95
Minority Interest in Earnings	-	-	-	-	-0.21
Net Income	1,492	1,364	1,307	1,073	976.74
Net Income to Common	1,492	1,364	1,307	1,073	976.74
Net Income Growth	9.41%	4.35%	21.85%	9.81%	21.76%
Shares Outstanding (Basic)	55	55	55	55	55
Shares Outstanding (Diluted)	55	55	55	55	55
Shares Change (YoY)	0.07%	0.08%	-0.05%	0.33%	6.37%
EPS (Basic)	26.95	24.66	23.67	19.46	17.81
EPS (Diluted)	26.93	24.63	23.62	19.38	17.70
EPS Growth	9.34%	4.28%	21.88%	9.49%	14.41%
Free Cash Flow	-1,996	-210.69	-880.28	1,187	-88.67
Free Cash Flow Per Share	-36.02	-3.81	-15.91	21.44	-1.61
Dividend Per Share	0.500	0.500	0.500	0.500	0.500
Gross Margin	30.36%	30.81%	28.94%	28.95%	25.01%
Operating Margin	8.63%	9.00%	9.98%	9.16%	8.71%
Profit Margin	6.23%	6.56%	7.14%	6.48%	6.59%
Free Cash Flow Margin	-8.33%	-1.01%	-4.81%	7.17%	-0.60%
EBITDA	2,859	2,486	2,418	2,138	1,768
EBITDA Margin	11.93%	11.95%	13.21%	12.91%	11.92%
D&A For EBITDA	791.24	613.57	591.25	621.4	476
EBIT	2,068	1,872	1,827	1,516	1,292
EBIT Margin	8.63%	9.00%	9.98%	9.16%	8.71%
Effective Tax Rate	26.32%	26.36%	26.42%	25.63%	28.31%
Revenue as Reported	24,187	20,843	18,380	16,614	14,950

Source: S&P Global Market Intelligence. Standard template. Financial Sources.